Gene: CYB5A
Official Full Name: cytochrome b5 type Aprovided by HGNC
Gene Summary: The protein encoded by this gene is a membrane-bound cytochrome that reduces ferric hemoglobin (methemoglobin) to ferrous hemoglobin, which is required for stearyl-CoA-desaturase activity. Defects in this gene are a cause of type IV hereditary methemoglobinemia. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO38341 | CYB5A Knockout cell line (HeLa) | Human | CYB5A | 1:3~1:6 | Negative | Online Inquiry |
KO38342 | CYB5A Knockout cell line (HCT 116) | Human | CYB5A | 1:2~1:4 | Negative | Online Inquiry |
KO38343 | CYB5A Knockout cell line (HEK293) | Human | CYB5A | 1:3~1:6 | Negative | Online Inquiry |
KO38344 | CYB5A Knockout cell line (A549) | Human | CYB5A | 1:3~1:4 | Negative | Online Inquiry |
The CYB5A Gene Knockout Cell Lines are engineered cell lines that exhibit a targeted knockout of the CYB5A gene, which encodes for cytochrome b5, a membrane-bound electron transport protein involved in various metabolic processes. These cell lines serve as vital tools for studying the physiological roles of cytochrome b5 in cellular metabolism, drug metabolism, and lipid biosynthesis. By completely disabling the CYB5A gene, researchers can isolate and investigate the resultant biochemical pathways more effectively, enabling deeper insights into metabolic regulation and dysfunction.
The key mechanism behind the functionality of CYB5A knockout cell lines lies in their altered redox state and modified enzymatic activities. Without CYB5A, cells display changes in the activity of enzymes involved in fatty acid desaturation and drug oxidation, impacting how cells respond to xenobiotics and endogenous metabolites. Such insights are essential for understanding variations in metabolism and drug response in clinical scenarios, offering a platform for researchers to explore metabolic diseases and pharmacogenomics.
Scientifically, these knockout cell lines are significant as they provide a unique model for studying disorders associated with altered cytochrome b5 functions, including certain metabolic and cardiovascular diseases. Their application extends to drug development, toxicology, and fundamental research in biochemistry, making them versatile tools in both academic and industrial settings.
Compared to traditional wild-type cell lines, CYB5A knockout cell lines offer a clear advantage by providing a controlled environment for dissecting the role of this specific gene. Researchers can achieve higher specificity in their experiments without confounding variables present in non-modified cell lines. This specificity not only streamline experimental design but also enhances the reproducibility of results.
For researchers and clinicians aiming to unravel complex metabolic pathways or develop novel therapeutic strategies, the CYB5A Gene Knockout Cell Lines are invaluable resources that can accelerate discoveries in molecular biology and pharmacology. Our company prides itself on its commitment to innovation and quality, supplying high-caliber biological products to the scientific community. With extensive expertise in gene editing technologies, we ensure that our products meet the highest standards for reliability and performance, enabling you to advance your research with confidence.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.